Metalloprotease inhibitors
Compounds of formula (I) and pharmaceutically-acceptable derivatives thereof, are matrix metalloprotease inhibitors, useful in treatment of conditions mediated by matrix metalloproteases, such as chronic dermal ulcers.
C C C C C C C
C07D C07D C07D C07D C07D C07D C07D
inventional inventional inventional inventional inventional inventional inventional
Kevin Neil Mark Llewellyn Gavin Alistair Nicholas Murray Michael Jonathan
Dack Lewis Whitlock Thomson Fray